227 related articles for article (PubMed ID: 35949006)
1. Broad application prospects of bone turnover markers in pediatrics.
Zhang Y; Huang X; Li C; Zhang J; Yu X; Li Y; Zhou W; Yu F
J Clin Lab Anal; 2022 Sep; 36(9):e24656. PubMed ID: 35949006
[TBL] [Abstract][Full Text] [Related]
2. Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (β-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP).
Diemar SS; Lylloff L; Rønne MS; Møllehave LT; Heidemann M; Thuesen BH; Johannesen J; Schou AJ; Husby S; Wedderkopp N; Mølgaard C; Jørgensen NR
Bone; 2021 May; 146():115879. PubMed ID: 33561588
[TBL] [Abstract][Full Text] [Related]
3. Reference intervals for bone turnover markers in Spanish premenopausal women.
Guañabens N; Filella X; Monegal A; Gómez-Vaquero C; Bonet M; Buquet D; Casado E; Cerdá D; Erra A; Martinez S; Montalá N; Pitarch C; Kanterewicz E; Sala M; Surís X; Torres F;
Clin Chem Lab Med; 2016 Feb; 54(2):293-303. PubMed ID: 26088062
[TBL] [Abstract][Full Text] [Related]
4. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
Shou Z; Jin X; Bian P; Li X; Chen J
Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
[TBL] [Abstract][Full Text] [Related]
5. The effects of acute exercise on bone turnover markers in middle-aged and older adults: A systematic review.
Smith C; Tacey A; Mesinovic J; Scott D; Lin X; Brennan-Speranza TC; Lewis JR; Duque G; Levinger I
Bone; 2021 Feb; 143():115766. PubMed ID: 33227507
[TBL] [Abstract][Full Text] [Related]
6. Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health in Men study.
Chubb SA; Byrnes E; Manning L; Beilby JP; Ebeling PR; Vasikaran SD; Golledge J; Flicker L; Yeap BB
J Clin Endocrinol Metab; 2015 Jan; 100(1):90-9. PubMed ID: 25322270
[TBL] [Abstract][Full Text] [Related]
7. Reference intervals for serum concentrations of three bone turnover markers for men and women.
Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
[TBL] [Abstract][Full Text] [Related]
8. Impact of vitamin D supplementation on markers of bone turnover: Systematic review and meta-analysis of randomised controlled trials.
Sohouli MH; Wang S; Almuqayyid F; Gabiatti MP; Mozaffari F; Mohamadian Z; Koushki N; Alras KA; AlHossan AM; Albatati SK; Alfardous Alazm A; Baradwan S; Găman MA; Wang S; Abu-Zaid A
Eur J Clin Invest; 2023 Oct; 53(10):e14038. PubMed ID: 37314058
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of measurement of bone turnover markers in female patients with systemic lupus erythematosus.
Bogaczewicz J; Karczmarewicz E; Pludowski P; Zabek J; Kowalski J; Lukaszkiewicz J; Wozniacka A
Rev Bras Reumatol; 2015; 55(2):133-9. PubMed ID: 25583000
[TBL] [Abstract][Full Text] [Related]
10. Establishment of reference intervals for bone turnover markers in healthy Chinese older adults.
Sun LL; Cao RR; Wang JD; Zhang GL; Deng FY; Lei SF
Ann Hum Biol; 2023 Feb; 50(1):172-186. PubMed ID: 36882371
[TBL] [Abstract][Full Text] [Related]
11. Decreased markers of bone turnover in children and adolescents with type 1 diabetes.
Madsen JOB; Herskin CW; Zerahn B; Jørgensen NR; Olsen BS; Pociot F; Johannesen J
Pediatr Diabetes; 2020 May; 21(3):505-514. PubMed ID: 31970841
[TBL] [Abstract][Full Text] [Related]
12. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
[TBL] [Abstract][Full Text] [Related]
13. Bone Turnover Markers in Children: From Laboratory Challenges to Clinical Interpretation.
Ladang A; Rauch F; Delvin E; Cavalier E
Calcif Tissue Int; 2023 Feb; 112(2):218-232. PubMed ID: 35243530
[TBL] [Abstract][Full Text] [Related]
14. Positive association of glucagon with bone turnover markers in type 2 diabetes: A cross-sectional study.
Guo H; Sui C; Ge S; Cai J; Lin D; Guo Y; Wang N; Zhou Y; Ying R; Zha K; Gu T; Zhao Y; Lu Y; An Z
Diabetes Metab Res Rev; 2022 Sep; 38(6):e3550. PubMed ID: 35621313
[TBL] [Abstract][Full Text] [Related]
15. Current use of bone turnover markers in the management of osteoporosis.
Brown JP; Don-Wauchope A; Douville P; Albert C; Vasikaran SD
Clin Biochem; 2022; 109-110():1-10. PubMed ID: 36096182
[TBL] [Abstract][Full Text] [Related]
16. Age-related trends and reference intervals of cross-linked C-telopeptide of type I collagen and procollagen type I N-propeptide from a reference population of Sri Lankan adult women.
Rathnayake H; Lekamwasam S; Wickramatilake C; De Zoysa E; Lenora J
Arch Osteoporos; 2021 Nov; 16(1):164. PubMed ID: 34727246
[TBL] [Abstract][Full Text] [Related]
17. Are bone turnover markers associated with volumetric bone density, size, and strength in older men and women? The AGES-Reykjavik study.
Marques EA; Gudnason V; Sigurdsson G; Lang T; Johannesdottir F; Siggeirsdottir K; Launer L; Eiriksdottir G; Harris TB
Osteoporos Int; 2016 May; 27(5):1765-76. PubMed ID: 26630978
[TBL] [Abstract][Full Text] [Related]
18. Congenital hypophosphataemia in adults: determinants of bone turnover markers and amelioration of renal phosphate wasting following total parathyroidectomy.
McKenna MJ; Martin-Grace J; Crowley R; Twomey PJ; Kilbane MT
J Bone Miner Metab; 2019 Jul; 37(4):685-693. PubMed ID: 30238432
[TBL] [Abstract][Full Text] [Related]
19. Do bone turnover markers reflect changes in bone microarchitecture during treatment of patients with thyroid dysfunction?
Vinther CJ; Poulsen LH; Nicolaisen P; Obling ML; Brix TH; Hermann AP; Hegedüs L; Jørgensen NR; Hansen S; Bonnema SJ
J Endocrinol Invest; 2023 Feb; 46(2):345-358. PubMed ID: 36064878
[TBL] [Abstract][Full Text] [Related]
20. Value of C-telopeptide-cross-linked Type I collagen, osteocalcin, bone-specific alkaline phosphatase and procollagen Type I N-terminal propeptide in the diagnosis and prognosis of bone metastasis in patients with malignant tumors.
Zhao H; Han KL; Wang ZY; Chen Y; Li HT; Zeng JL; Shen Z; Yao Y
Med Sci Monit; 2011 Nov; 17(11):CR626-633. PubMed ID: 22037741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
